Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: An institutional urban clinic experience
Widespread introduction of highly active antiretroviral therapy (HAART) in the mid 1990s has altered the presentation of the cutaneous manifestations associated with HIV infection. Our purpose was to evaluate the use of HAART on the prevalence and spectrum of cutaneous manifestations in HIV-infected...
Gespeichert in:
Veröffentlicht in: | Journal of the American Academy of Dermatology 2006-04, Vol.54 (4), p.581-588 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 588 |
---|---|
container_issue | 4 |
container_start_page | 581 |
container_title | Journal of the American Academy of Dermatology |
container_volume | 54 |
creator | Zancanaro, Pedro C. Queiroz McGirt, Laura Y. Mamelak, Adam J. Nguyen, Ruby H.-N. Martins, Ciro R. |
description | Widespread introduction of highly active antiretroviral therapy (HAART) in the mid 1990s has altered the presentation of the cutaneous manifestations associated with HIV infection.
Our purpose was to evaluate the use of HAART on the prevalence and spectrum of cutaneous manifestations in HIV-infected patients.
A study of the initial visits of 897 HIV-infected patients at an urban dermatology clinic between 1996 and 2002 was performed.
Folliculitis was the most common cutaneous disorder identified. Patients with CD4-positive cell counts less than 200 cells/mm
3 had an increased prevalence of folliculitis and prurigo nodularis, whereas those with HIV viral loads higher than 55,000 copies/mL had a higher prevalence of idiopathic pruritus and candidiasis. Patients not receiving HAART had increased rates of folliculitis and prurigo nodularis. Patients receiving HAART had increased rates of photosensitivity and molluscum contagiosum.
This was a cross-sectional study in which temporality was unable to be determined.
With ongoing therapeutic advancements, the cutaneous manifestations associated with HIV infection will continue to evolve. |
doi_str_mv | 10.1016/j.jaad.2005.12.030 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67762404</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S019096220504956X</els_id><sourcerecordid>67762404</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-517ed4e71a1af02ca49e31edded5977b3d92b2b8b69959a7dce2c237eceffbbd3</originalsourceid><addsrcrecordid>eNp9kE1rGzEQhkVpaZy0f6CHoktz262k_ZAVcjGmbQKBXppcxaw0W8usta6kNTH0x1cbG3LrSTB63peZh5BPnJWc8fbrttwC2FIw1pRclKxib8iCMyWLVi7lW7JgXLFCtUJckMsYt4wxVVfyPbngbVO3jVwuyN_1lMDjOEW6A-96jAmSG32kY0_v7p-o8zRtkGKAebJxvzfDkYJJ7oAUfHIBUxgPLsAwcwH2xxu68jkWk0vTXJV_ptCBp2Zw3hmKz3sMDr3BD-RdD0PEj-f3ijx-__ZrfVc8_Pxxv149FKZuWCoaLtHWKDlw6JkwUCusOFqLtlFSdpVVohPdsmuVahRIa1AYUUk02PddZ6srcn3q3Yfxz5RP1DsXDQ7D6XLdStmKmtUZFCfQhDHGgL3eB7eDcNSc6dm53urZuZ6day50dp5Dn8_tU7dD-xo5S87AlzMA0cDQB_DGxVdOSiaVqDJ3e-Iwuzg4DDqaF082WzZJ29H9b49_su6jGA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67762404</pqid></control><display><type>article</type><title>Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: An institutional urban clinic experience</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Zancanaro, Pedro C. Queiroz ; McGirt, Laura Y. ; Mamelak, Adam J. ; Nguyen, Ruby H.-N. ; Martins, Ciro R.</creator><creatorcontrib>Zancanaro, Pedro C. Queiroz ; McGirt, Laura Y. ; Mamelak, Adam J. ; Nguyen, Ruby H.-N. ; Martins, Ciro R.</creatorcontrib><description>Widespread introduction of highly active antiretroviral therapy (HAART) in the mid 1990s has altered the presentation of the cutaneous manifestations associated with HIV infection.
Our purpose was to evaluate the use of HAART on the prevalence and spectrum of cutaneous manifestations in HIV-infected patients.
A study of the initial visits of 897 HIV-infected patients at an urban dermatology clinic between 1996 and 2002 was performed.
Folliculitis was the most common cutaneous disorder identified. Patients with CD4-positive cell counts less than 200 cells/mm
3 had an increased prevalence of folliculitis and prurigo nodularis, whereas those with HIV viral loads higher than 55,000 copies/mL had a higher prevalence of idiopathic pruritus and candidiasis. Patients not receiving HAART had increased rates of folliculitis and prurigo nodularis. Patients receiving HAART had increased rates of photosensitivity and molluscum contagiosum.
This was a cross-sectional study in which temporality was unable to be determined.
With ongoing therapeutic advancements, the cutaneous manifestations associated with HIV infection will continue to evolve.</description><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2005.12.030</identifier><identifier>PMID: 16546578</identifier><identifier>CODEN: JAADDB</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adult ; Antiretroviral Therapy, Highly Active ; Biological and medical sciences ; Child ; Dermatology ; Female ; HIV Infections - complications ; HIV Infections - drug therapy ; HIV Infections - virology ; Human viral diseases ; Humans ; Infectious diseases ; Male ; Medical sciences ; Middle Aged ; Skin Diseases - complications ; Skin Diseases - pathology ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Viral Load</subject><ispartof>Journal of the American Academy of Dermatology, 2006-04, Vol.54 (4), p.581-588</ispartof><rights>2006 American Academy of Dermatology, Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-517ed4e71a1af02ca49e31edded5977b3d92b2b8b69959a7dce2c237eceffbbd3</citedby><cites>FETCH-LOGICAL-c450t-517ed4e71a1af02ca49e31edded5977b3d92b2b8b69959a7dce2c237eceffbbd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaad.2005.12.030$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17707923$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16546578$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zancanaro, Pedro C. Queiroz</creatorcontrib><creatorcontrib>McGirt, Laura Y.</creatorcontrib><creatorcontrib>Mamelak, Adam J.</creatorcontrib><creatorcontrib>Nguyen, Ruby H.-N.</creatorcontrib><creatorcontrib>Martins, Ciro R.</creatorcontrib><title>Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: An institutional urban clinic experience</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><description>Widespread introduction of highly active antiretroviral therapy (HAART) in the mid 1990s has altered the presentation of the cutaneous manifestations associated with HIV infection.
Our purpose was to evaluate the use of HAART on the prevalence and spectrum of cutaneous manifestations in HIV-infected patients.
A study of the initial visits of 897 HIV-infected patients at an urban dermatology clinic between 1996 and 2002 was performed.
Folliculitis was the most common cutaneous disorder identified. Patients with CD4-positive cell counts less than 200 cells/mm
3 had an increased prevalence of folliculitis and prurigo nodularis, whereas those with HIV viral loads higher than 55,000 copies/mL had a higher prevalence of idiopathic pruritus and candidiasis. Patients not receiving HAART had increased rates of folliculitis and prurigo nodularis. Patients receiving HAART had increased rates of photosensitivity and molluscum contagiosum.
This was a cross-sectional study in which temporality was unable to be determined.
With ongoing therapeutic advancements, the cutaneous manifestations associated with HIV infection will continue to evolve.</description><subject>Adult</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Dermatology</subject><subject>Female</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - virology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Skin Diseases - complications</subject><subject>Skin Diseases - pathology</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Viral Load</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1rGzEQhkVpaZy0f6CHoktz262k_ZAVcjGmbQKBXppcxaw0W8usta6kNTH0x1cbG3LrSTB63peZh5BPnJWc8fbrttwC2FIw1pRclKxib8iCMyWLVi7lW7JgXLFCtUJckMsYt4wxVVfyPbngbVO3jVwuyN_1lMDjOEW6A-96jAmSG32kY0_v7p-o8zRtkGKAebJxvzfDkYJJ7oAUfHIBUxgPLsAwcwH2xxu68jkWk0vTXJV_ptCBp2Zw3hmKz3sMDr3BD-RdD0PEj-f3ijx-__ZrfVc8_Pxxv149FKZuWCoaLtHWKDlw6JkwUCusOFqLtlFSdpVVohPdsmuVahRIa1AYUUk02PddZ6srcn3q3Yfxz5RP1DsXDQ7D6XLdStmKmtUZFCfQhDHGgL3eB7eDcNSc6dm53urZuZ6day50dp5Dn8_tU7dD-xo5S87AlzMA0cDQB_DGxVdOSiaVqDJ3e-Iwuzg4DDqaF082WzZJ29H9b49_su6jGA</recordid><startdate>20060401</startdate><enddate>20060401</enddate><creator>Zancanaro, Pedro C. Queiroz</creator><creator>McGirt, Laura Y.</creator><creator>Mamelak, Adam J.</creator><creator>Nguyen, Ruby H.-N.</creator><creator>Martins, Ciro R.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060401</creationdate><title>Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: An institutional urban clinic experience</title><author>Zancanaro, Pedro C. Queiroz ; McGirt, Laura Y. ; Mamelak, Adam J. ; Nguyen, Ruby H.-N. ; Martins, Ciro R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-517ed4e71a1af02ca49e31edded5977b3d92b2b8b69959a7dce2c237eceffbbd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Dermatology</topic><topic>Female</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - virology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Skin Diseases - complications</topic><topic>Skin Diseases - pathology</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Viral Load</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zancanaro, Pedro C. Queiroz</creatorcontrib><creatorcontrib>McGirt, Laura Y.</creatorcontrib><creatorcontrib>Mamelak, Adam J.</creatorcontrib><creatorcontrib>Nguyen, Ruby H.-N.</creatorcontrib><creatorcontrib>Martins, Ciro R.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zancanaro, Pedro C. Queiroz</au><au>McGirt, Laura Y.</au><au>Mamelak, Adam J.</au><au>Nguyen, Ruby H.-N.</au><au>Martins, Ciro R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: An institutional urban clinic experience</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2006-04-01</date><risdate>2006</risdate><volume>54</volume><issue>4</issue><spage>581</spage><epage>588</epage><pages>581-588</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><coden>JAADDB</coden><abstract>Widespread introduction of highly active antiretroviral therapy (HAART) in the mid 1990s has altered the presentation of the cutaneous manifestations associated with HIV infection.
Our purpose was to evaluate the use of HAART on the prevalence and spectrum of cutaneous manifestations in HIV-infected patients.
A study of the initial visits of 897 HIV-infected patients at an urban dermatology clinic between 1996 and 2002 was performed.
Folliculitis was the most common cutaneous disorder identified. Patients with CD4-positive cell counts less than 200 cells/mm
3 had an increased prevalence of folliculitis and prurigo nodularis, whereas those with HIV viral loads higher than 55,000 copies/mL had a higher prevalence of idiopathic pruritus and candidiasis. Patients not receiving HAART had increased rates of folliculitis and prurigo nodularis. Patients receiving HAART had increased rates of photosensitivity and molluscum contagiosum.
This was a cross-sectional study in which temporality was unable to be determined.
With ongoing therapeutic advancements, the cutaneous manifestations associated with HIV infection will continue to evolve.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>16546578</pmid><doi>10.1016/j.jaad.2005.12.030</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0190-9622 |
ispartof | Journal of the American Academy of Dermatology, 2006-04, Vol.54 (4), p.581-588 |
issn | 0190-9622 1097-6787 |
language | eng |
recordid | cdi_proquest_miscellaneous_67762404 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adult Antiretroviral Therapy, Highly Active Biological and medical sciences Child Dermatology Female HIV Infections - complications HIV Infections - drug therapy HIV Infections - virology Human viral diseases Humans Infectious diseases Male Medical sciences Middle Aged Skin Diseases - complications Skin Diseases - pathology Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral Load |
title | Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: An institutional urban clinic experience |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A05%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cutaneous%20manifestations%20of%20HIV%20in%20the%20era%20of%20highly%20active%20antiretroviral%20therapy:%20An%20institutional%20urban%20clinic%20experience&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Zancanaro,%20Pedro%20C.%20Queiroz&rft.date=2006-04-01&rft.volume=54&rft.issue=4&rft.spage=581&rft.epage=588&rft.pages=581-588&rft.issn=0190-9622&rft.eissn=1097-6787&rft.coden=JAADDB&rft_id=info:doi/10.1016/j.jaad.2005.12.030&rft_dat=%3Cproquest_cross%3E67762404%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67762404&rft_id=info:pmid/16546578&rft_els_id=S019096220504956X&rfr_iscdi=true |